Page last updated: 2024-08-24

triazoles and melphalan

triazoles has been researched along with melphalan in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Helenglass, G; Jones, A; Milliken, S; Powles, R1
Ara, G; Chen, YN; Holden, SA; Korbut, TT; Northey, D; Teicher, BA1
Babu, H; Jiang, J; Kagan, VE; Kai, M; Kini, V; Kusumoto, C; Matsura, T; Yamada, K1
Dinser, R; Grgic, A; Kim, YJ; Pfreundschuh, M; Schubert, J1
Bauer, AA; Cubitt, CL; Cui, Y; Dalton, WS; Dawson, JL; Gomez, JA; Kim, J; Nishihori, T; Sullivan, DM; Turner, JG1
Banerjee, A; Berdeja, JG; Deraedt, W; Diels, J; Jackson, CC; Jagannath, S; Krishnan, A; Martin, T; Nesheiwat, T; Schecter, JM; Usmani, SZ; Valluri, S; Van Sanden, S; Vogel, M; Weisel, K; Yalniz, F; Yeh, TM1

Trials

1 trial(s) available for triazoles and melphalan

ArticleYear
Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HOR
    Clinical lymphoma, myeloma & leukemia, 2022, Volume: 22, Issue:9

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Hydrazines; Melphalan; Multiple Myeloma; Triazoles

2022

Other Studies

5 other study(ies) available for triazoles and melphalan

ArticleYear
Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan.
    Transplantation proceedings, 1989, Volume: 21, Issue:1 Pt 3

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Bone Marrow Transplantation; Drug Administration Schedule; Female; Fluconazole; Humans; Male; Melphalan; Middle Aged; Mycoses; Transplantation, Autologous; Triazoles; Whole-Body Irradiation

1989
CAI: effects on cytotoxic therapies in vitro and in vivo.
    Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:6

    Topics: Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carmustine; Cisplatin; Cyclophosphamide; Fibrosarcoma; Mammary Neoplasms, Experimental; Melphalan; Mice; Triazoles; Tumor Cells, Cultured

1994
Endogenously generated hydrogen peroxide is required for execution of melphalan-induced apoptosis as well as oxidation and externalization of phosphatidylserine.
    Chemical research in toxicology, 2004, Volume: 17, Issue:5

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; bcl-2-Associated X Protein; Catalase; Cytochromes c; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Melphalan; Mitochondria; Oxidation-Reduction; Phosphatidylserines; Proto-Oncogene Proteins c-bcl-2; Superoxide Dismutase; Triazoles; Tumor Cells, Cultured

2004
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell
    European journal of haematology, 2005, Volume: 74, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Granulocytes; Humans; Leukocyte Transfusion; Lipopeptides; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Myeloma; Necrosis; Peptides, Cyclic; Pyrimidines; Radiography; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole

2005
Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma.
    Cancer research, 2020, 12-01, Volume: 80, Issue:23

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Exportin 1 Protein; Fanconi Anemia Complementation Group D2 Protein; Humans; Hydrazines; Karyopherins; Melphalan; Mice, Inbred NOD; Multiple Myeloma; Nestin; Receptors, Cytoplasmic and Nuclear; Triazoles; Ubiquitination; Xenograft Model Antitumor Assays

2020